Gain A Better Understanding of Psoriasis on CME Webcast

OSUWexnerbloglogo2014 Gain A Better Understanding of Psoriasis on CME Webcast. Over the centuries, thousands of treatments have been tried and thousands of treatments have failed. But the good news is that in the past few years there have been effective new biologic agents developed that are offering hope to patients with the most severe cases of psoriasis. Joining us on our webcast to discuss the diagnosis and management of psoriasis is dermatologist and Assistant Professor of Internal Medicine, Dr. Jessica Kaffenberger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the different types of psoriasis and how to effectively treat them; DESCRIBE the pathogenesis of psoriasis and how it correlates with the newest therapies; and IDENTIFY frequent psoriasis co-morbidities that affect medication management.

You’ll also learn about the following:

  • The etiology of psoriasis
  • New directions in treating psoriasis
  • The role of skin biopsy
  • Psoriasis versus eczema
  • Long-term prognosis for patients with psoriasis
  • Relationship of diet, exercise, and sunlight with psoriasis
  • Deodorants and common skin lotions
  • Swimming with psoriasis
  • Treatment of psoriatic arthritis
  • Precautions for patients taking methotrexate
  • Genital psoriasis and sexual health

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Enduring Material Teaches Physicians on Inflammatory Bowel Disease

OSUWexnerbloglogo2014 On-line CME Enduring Material Teaches Physicians on Inflammatory Bowel Disease. We have come a long way since Crohn, Ginzburg, and Oppenheimer first described inflammatory bowel disease. On this CME Webcast, we’re going to bring you up to date on Crohn’s disease and ulcerative colitis, what they are, how to diagnose them and new treatments for inflammatory bowel disease. We’re pleased to have the Medical Director of the OSU Inflammatory Bowel Disease Center, gastroenterologist and Assistant Professor of Internal Medicine, Dr. Anita Afzali joining us on the program.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the role of the primary care provider (PCP) in IBD; and DEVELOP a health maintenance plan for the patient with IBD.

You’ll also learn about the following:

  • Etiology of inflammatory bowel disease
  • New developments in treatment of inflammatory bowel disease
  • Diet and inflammatory bowel disease
  • Pregnancy and inflammatory bowel disease
  • Management of small bowel obstruction and acute exacerbations of pain
  • Duration of biologic therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Drugs for Lipid Management

OSUWexnerbloglogo2014 Learn About New Drugs for Lipid Management. Managing hyperlipidemia used to be so easy. If a patient’s total cholesterol was greater than 200, then we started them on lovastatin to reduce it. But things are a lot more complicated now. There isn’t a single cholesterol target for all patients and we have gone way beyond statins as the only game in town for cholesterol management. On this CME webcast, we’re going to update you on the newest developments in lipid management. What tests to order, who to treat and which drugs to use. Joining our moderator in the studio is cardiologist and Associate Professor of Internal Medicine, Dr. John Larry and pharmacist and Assistant Professor of Pharmacy, Melissa Snider.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW updates in approaches to treatment of dyslipidemia; DISCUSS recent evidence for non-statin lipid lowering therapies; DISCUSS place in therapy of available lipid lowering therapies; and REVIEW clinical approach to statin intolerance.

You’ll also learn about the following:

  • Patient-specific cholesterol targets
  • Multidisciplinary lipid clinics at the OSU Wexner Medical Center
  • The expanding role of pharmacists in outpatient clinical practice
  • Diet and cholesterol

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

View Obesity and Bariatric Surgery Webcast

OSUWexnerbloglogo2014 View Obesity and Bariatric Surgery Webcast. The U.S. Surgeon General estimates that obesity contributes to 112,000 preventable deaths each year. And deaths are only the tip of the obesity iceberg. The medical problems caused by obesity are enormous: coronary disease, diabetes, cancer, hypertension, hyperlipidemia, stroke, liver disease, gallstones, sleep apnea, and osteoarthritis, just to name a few. For many physicians, the advice to patients is to eat fewer calories and exercise more. But unfortunately, that advice usually just isn’t enough for most patients. On this CME Webcast, we’re going to show you what can work for your patients when diet and exercise don’t work. Joining Dr. Jim Allen in the studio is nurse practitioner and specialist in the medical management of obesity from the Ohio State University Comprehensive Weight Management Program, Kathy Foreman. Also in the studio, from the Division of General Surgery, is bariatric surgeon and Associate Professor of Surgery, Dr. Bradley Needleman.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the health risks associated with obesity; DESCRIBE the options for the treatment of adult obesity; and RECOGNIZE non-surgical treatment options for obesity including.

You’ll also learn about the following:

  • Effectiveness of non-surgical weight loss treatments
  • Trends in bariatric surgical procedures
  • Realistic weight loss goals
  • The OSU Wexner Medical Center Comprehensive Weight Management Program
  • Follow up management of the patient after bariatric surgery
  • Pre-operative evaluation of the bariatric surgery patient
  • Management of the “super obese” patients with BMI > 50
  • Whether weight loss medications should be combined
  • Changing to different medications
  • Choosing a diet
  • Insurance coverage for bariatric surgery

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn Latest about Pancreatic Cancer

OSUWexnerbloglogo2014 Learn Latest about Pancreatic Cancer.  It seems as though about all physicians learned about the Whipple procedure in medical school and that is what most physicians associate with the surgical treatment of pancreatic cancer. But what has happened in the 80 years since Allen Whipple did his first pancreatic surgery? Well, we now understand pancreatic cancer much better and we have a rapidly expanding repertoire of surgical procedures that can be used in pancreatic cancer. On our CME Webcast today, to tell us about the current approach to pancreatic cancer, are two of Ohio State’s top experts in the disease. First, we have Dr. Peter Muscarella who is an Associate Professor of Surgery from the Division of General Surgery.  Also joining him is Dr. Mark Bloomston, an Associate Professor of Surgery from the Division of Surgical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the indications for curative resection for pancreatic cancer; to RECOGNIZE the role of new chemotherapy regimens in patients with advanced pancreatic cancer; to REVIEW the epidemiology and diagnostic evaluation of pancreatic cancer; and to DESCRIBE recent advances in staging and multimodality treatment for pancreatic cancer.

You’ll also learn about the following:

  • Why pancreatic cancer frequently presents in advanced stage
  • Current treatment options for pancreatic cancer
  • Screening for pancreatic cancer
  • Biopsy approaches
  • Weight loss, diet, and pancreatic cancer
  • The role of the primary care provider in follow up of pancreatic cancer
  • Advanced endoscopic techniques and pancreatic cancer
  • Histologic types of pancreatic cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.